CS logo
small CS logo
Praxis und Tagesklinik für Onkologie und Hämatologie

Recklinghausen, Germany
Medical office in Recklinghausen, North Rhine-Westphalia
Am Stadion 9, 45659 Recklinghausen

About Praxis und Tagesklinik für Onkologie und Hämatologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Praxis und Tagesklinik für Onkologie und Hämatologie


During the past decade, Praxis und Tagesklinik für Onkologie und Hämatologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis und Tagesklinik für Onkologie und Hämatologie" #1 collaborator was "Roche Pharma AG" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Praxis und Tagesklinik für Onkologie und Hämatologie


According to Clinical.Site data, the most researched conditions in "Praxis und Tagesklinik für Onkologie und Hämatologie" are "Breast Cancer" (2 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "HER 2 Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Praxis und Tagesklinik für Onkologie und Hämatologie" in a lesser frequency.

Clinical Trials Intervention Types at Praxis und Tagesklinik für Onkologie und Hämatologie


Most popular intervention types in "Praxis und Tagesklinik für Onkologie und Hämatologie" are "Drug" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (1 trials), "Capecitabine + bevacizumab OR Paclitaxel +/- bevacizumab" (1 trials), "Pertuzumab" (1 trials), "Ribociclib and aromatase inhibitor or fulvestrant" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Praxis und Tagesklinik für Onkologie und Hämatologie


The vast majority of trials in "Praxis und Tagesklinik für Onkologie und Hämatologie" are 4 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Praxis und Tagesklinik für Onkologie und Hämatologie


Currently, there are NaN active trials in "Praxis und Tagesklinik für Onkologie und Hämatologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Praxis und Tagesklinik für Onkologie und Hämatologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Praxis und Tagesklinik für Onkologie und Hämatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".